Insider Shareholders with Direct Ownership of Brainstorm Cell Therapeutics Inc. (BCLI)
This section provides a comprehensive overview of the insiders with direct ownership of Brainstorm Cell Therapeutics Inc. (BCLI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BRAINSTORM CELL THERAPEUTICS INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Stacy Lindborg
Co-Chief Executive Officer |
398,435 | 0 | 423,435 $516,590 | 5 |
Mar 11, 2024
Added 36.36%
|
|
Ralph Dr. Kern
COO and Chief Medical Officer |
71,770 | 0 | 223,310 $272,438 | 2 |
Mar 06, 2022
Added 13.84%
|
|
Uri Yablonka
EVP & Chief Business Officer |
109,426 | 0 | 126,969 $154,902 | 1 |
Mar 11, 2024
Added 46.29%
|
|
Chaim Lebovits
President & CEO |
1,063,961 | 0 | 80,960 $98,771 | 18 |
Oct 01, 2024
Added 2.22%
|
|
Malcolm S Taub
Director |
24,000 | 0 | 77,332 $94,345 | 2 |
Dec 15, 2021
Added 13.43%
|
|
Alla Patlis
Officer |
65,246 | 0 | 65,246 $79,600 | 1 |
Mar 11, 2024
Added 50.0%
|
|
Kirk Taylor
Chief Medical Officer |
35,000 | 0 | 35,000 $42,700 | 1 |
May 01, 2023
Added 50.0%
|
|
Hartoun Hartounian
EVP, Chief Operating Officer |
30,000 | 0 | 30,000 $36,600 | 1 |
Jun 24, 2024
Added 50.0%
|
|
Anthony J. Polverino
Director |
10,098 | 0 | 25,960 $31,671 | 3 |
Feb 01, 2022
Added 13.01%
|
|
Nir Naor
Director |
11,999 | 0 | 11,999 $14,638 | 1 |
Jun 19, 2023
Added 50.0%
|
|
Preetam Shah
EVP, CFO and Treasurer |
0 | 25,000 | 11,600 $14,152 | 1 |
Dec 30, 2020
Reduced 68.31%
|
|
Sankesh Abbhi
Director |
6,666 | 0 | 11,323 $13,814 | 1 |
Dec 10, 2021
Added 37.06%
|
|
June Sherie Almenoff
Director |
4,000 | 0 | 6,000 $7,320 | 2 |
Dec 15, 2021
Added 25.0%
|
|
Ibrahim B. Dagher
Chief Medical Officer |
0 | 63,000 | 0 $0 | 1 |
Jul 19, 2024
Reduced 100.0%
|